In a study we performed earlier, we observed higher mRNA levels of APOBEC3B in breast cancer metastasis as compared to the corresponding primary tumor [14], supporting our hypothesis that, already starting from DCIS, breast cancer progression is associated with deregulated expression of APOBEC3B. Here, APOBEC3B is linked to ductal breast carcinoma in situ.